PSM News
Colorado updates drug importation proposal, cuts list of meds by 88, adds Ozempic
Colorado’s updated Canadian drug importation application to the FDA cuts the drug list from 112 to 24 and adds Ozempic to the list of medicines it wants from Canadians.
[...]Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision
PSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
[...]PSM Response To The Pandemic and All-Hazards Preparedness Act (PAHPA) Request For Information
PSM provided our thoughts to the US Senate Health, Education, Labor, and Pensions committee when they requested input on the authorization of the Pandemic All Hazards Preparedness Act.
[...]Watch PSM’s Briefing for the 118th Congress, Washington D.C., February 28, 2023
On Tuesday, February 28, 2023, the Partnership for Safe Medicines convened pharmacists, law enforcement, policy experts and family advocates to educate legislators about key issues in the fight against counterfeit medicines. Learn more and watch the briefing here.
[...]A Campaign to Spread the Word About Fake Pill Deaths in the Central Valley of California
When the Central Valley Opioid Safety Commission contacted us about helping them promote a public safety message about the dangers of counterfeit pills made with fentanyl, of course we said yes. Their 30-second spot featured the family of Travis Jacobson, a young Californian who was tragically killed by a fake Xanax pill that turned out to be lethal. We at PSM were happy to underwrite both the direct costs and the labor costs of such an important public health message.
[...]Statement on Trump Administration Executive Order on Drug Importation
Washington, D.C. (July 24, 2020) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to President Trump’s executive order signed today on the importation of prescription drugs:
[...]PSM Statement on the passage of S.3201, which extends the DEA’s temporary scheduling of fentanyl-related substances as Schedule I for 15 months.
The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…
[...]HHS Announces Dangerous Draft Regulations for Importing Drugs from Canada
Partnership for Safe Medicines Statement on Proposed Regulations to Import Prescription Medicines from Canada Washington, D.C. (December 18, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines: “Citizens of…
[...]PSM’s Executive Director Speaks on Morning Wakeup with Dave Akerly to Warn Michigan Residents about the Dangers of Drug Importation
PSM’s Executive Director Shabbir Safdar spoke with Dave Akerly on WILS in Lansing, Michigan about the importation proposal currently being debated in the Michigan House of Representatives. Safdar was enroute to the Michigan State House to participate in hearings on drug importation being held there. Here why our Executive Director has travelled to Michigan to testify at their drug importation hearing.
[...]Bloomberg Misses The Mark In Its Article About Drug Importation Advocacy
In case you missed it, Bloomberg’s Ben Elgin has published an “in-depth” piece on the connection between PhRMA and the Partnership for Safe Medicines. However, this has been public and widely reported on for years. More concerningly, the story misses the broader point about the clear safety concerns of foreign drug importation. Over the past…
[...]